Organigram Global Inc. (OGI) vs Organogenesis (ORGO)
- Organigram Global Inc. OGI 0.93 0.00%
- Organogenesis ORGO 0.99 −10.81%
Organigram Global Inc. and Organogenesis are both Drug Manufacturers Specialty & Generic companies. Organigram Global Inc. and Organogenesis are of similar size ($142.8M and $131.4M). Organogenesis has negative trailing earnings, so its P/E is not meaningful; Organigram Global Inc. trades at 2.0×. Organigram Global Inc. grew revenue faster over the last twelve months: 39.5% against 6.50%. Organigram Global Inc. has the higher net margin (28.4% vs −22.2%) and the higher return on invested capital (−1.53% vs −20.0%). Across the 19 metrics below, Organigram Global Inc. leads on 11 and Organogenesis on 8.
Valuation
Profitability
| Metric | OGI | ORGO | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 36.47% | 70.35% | 53.94% |
| Operating margin | (3.91%) | (7.84%) | 0.00% |
| Net margin | 28.44% | (22.23%) | 0.00% |
| Free cash flow margin | (9.46%) | 4.56% | 0.00% |
| Return on equity | 20.20% | (53.31%) | (0.40%) |
| Return on assets | 12.70% | (23.44%) | (3.32%) |
| Return on invested capital | (1.53%) | (19.97%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack